Immodulon Therapeutics Limited
Biotechnology - London, England, United Kingdom
Immodulon Therapeutics Limited Employees
Immodulon Therapeutics Limited Details
IMMODULON, LEADERS IN IMMUNO-ONCOLOGYImmodulon Therapeutics Ltd. is a privately-owned clinical-stage immuno-oncology company primarily focused on the development of safe, effective and novel treatments for cancer. Its lead drug candidate, IMM-101, has shown promise in early clinical trials, demonstrating potential for the platform. IMM-101 has a unique mechanism of action that should not only make this innovative product applicable to a large range of cancers but, in combination with immune checkpoint inhibitors and other standard-of-care treatments, is expected to enhance their efficacy without increasing the safety burden for the patient.
Immodulon Therapeutics Limited Technologies
Email Providers
Mimecast
Domain Name Services
Cloudflare DNS
Hosting
DigitalOcean
Online Video Platforms
YouTube
Other
Mobile Friendly
Analytics and Tracking
Google Analytics